Arizona

Arizona has emerged as a premier global destination for life sciences, characterized by a high-growth ecosystem that seamlessly integrates biotechnology, pharmaceuticals and medical device manufacturing.

At the heart of this "collaborative gene" is the Phoenix Bioscience Core (PBC), a high-density innovation district anchoring world-class academic research from Arizona State University, University of Arizona and Northern Arizona University.

The state is globally recognized for its leadership in precision medicine and genomics, pioneered by the Translational Genomics Research Institute (TGen) and supported by elite clinical partners like Mayo Clinic and Banner Health.

Arizona's healthcare innovation is further propelled by a robust medtech sector, with industry giants like Medtronic, BD and Roche Tissue Diagnostics driving advancements in surgical robotics and diagnostics.

Beyond R&D, the state's advanced manufacturing infrastructure and favorable business climate have attracted significant biomanufacturing and cell and gene therapy investments.

With annual research expenditures surpassing $1 billion and a specialized workforce fueled by a top-tier bioscience roadmap, Arizona offers an unparalleled environment for translational research and clinical trials.

As an expanding hub for digital health and AI-driven drug discovery, Arizona continues to scale its impact on global health outcomes.